StockData
ELI LILLY & Co logo

ELI LILLY & Co (LLY) operating KPIs

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)

Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%

Eli Lilly lilly 30x30 Global Health — People reached annually in resource-limited settings (millions) (M)

Lilly 2024 Sustainability Report & 2025 Sustainability Highlights Report

Latest, FY2025
40
Period ended Dec 31, 2025
Change on a year earlier
+66.7%
24 in FY2024
History
5 years
Since FY2021
Sources
1
Lilly 2025 Sustainability Highlights Report

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedLilly 30x30 Global Health — People reached annually in resource-limited settings (millions) (M)Year on yearSource
FY2025Dec 31, 202540+66.7%Lilly 2025 Sustainability Highlights Report ↗
FY2024Dec 31, 202424+33.3%Lilly 2025 Sustainability Highlights Report ↗
FY2023Dec 31, 202318+38.5%Lilly 2025 Sustainability Highlights Report ↗
FY2022Dec 31, 202213+18.2%Lilly 2025 Sustainability Highlights Report ↗
FY2021Dec 31, 202111–Lilly 2025 Sustainability Highlights Report ↗

Cite this data

StockData. (2026). Eli Lilly Lilly 30x30 Global Health — People reached annually in resource-limited settings (millions) (M), annual FY2021–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/esg_30x30_patients_m

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.